MedPath

Text Messaging for Smoking Cessation in College Health Clinics

Not Applicable
Completed
Conditions
Cigarette Smoking
Interventions
Behavioral: Smoking counseling
Behavioral: Text messaging
Drug: Nicotine patch
Registration Number
NCT02191033
Lead Sponsor
Yale University
Brief Summary

This study is a randomized-controlled clinical trial which evaluates the efficacy of physician brief advice, nicotine replacement therapy and a 6-week course of text messaging in promoting cigarette smoking in smokers enrolled in college.

The primary hypothesis is that smokers receiving physician brief advice, nicotine replacement therapy, and text messaging will have higher quit rates that smokers receiving physician brief advice and nicotine replacement therapy alone.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Aged 18 through 24 years
  • Enrolled as a full/part time college student
  • A current smoker (Have smoked more than 100 cigarettes in their lifetime and now smoke every day or some days)
  • English-speaking
  • Interested in quitting
  • Have a cell phone for personal use with an unlimited text messaging plan.
Read More
Exclusion Criteria
  • History of hypersensitivity/allergy to nicotine patch;
  • Serious arrhythmias - History of heart disease (myocardial infarction, severe chest pain, or coronary artery disease)
  • Current pregnancy/breastfeeding/plan for pregnancy
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard of careSmoking counselingSmoking counseling, nicotine patch
Text messagingSmoking counselingSmoking counseling, nicotine patch, text messaging
Text messagingText messagingSmoking counseling, nicotine patch, text messaging
Text messagingNicotine patchSmoking counseling, nicotine patch, text messaging
Standard of careNicotine patchSmoking counseling, nicotine patch
Primary Outcome Measures
NameTimeMethod
Study Enrollment- Number of Participants Who Join the Studybaseline

We will report the number of persons who join the study.

Study Retention- Number of Participants Who Attend the 6- and 12-week Follow up Visits.6- and 12- weeks

We will determine the number of enrolled participants who follow up at the 6- and 12- week follow up visit.

Secondary Outcome Measures
NameTimeMethod
Smoking Abstinence6- and 12- weeks

biochemically confirmed point prevalence of self reported past 7-day abstinence

Trial Locations

Locations (1)

Southern Connecticut State University

🇺🇸

New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath